Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,975 | 118,021 | 69,197 | 49,663 | 58,358 |
| Marketable Securities | 133,098 | 210,178 | 77,472 | 79,889 | 117,275 |
| Receivables | 7,862 | N/A | N/A | N/A | N/A |
| Inventories | 346 | N/A | N/A | N/A | N/A |
| TOTAL | $278,570 | $334,612 | $148,423 | $131,636 | $177,600 |
| Non-Current Assets | |||||
| PPE Net | 3,046 | 3,863 | 2,185 | 2,836 | 3,483 |
| Investments And Advances | 2,016 | 2,001 | 29,396 | 45,434 | 33,878 |
| Other Non-Current Assets | 11,331 | 716 | 290 | 479 | 482 |
| TOTAL | $16,393 | $6,580 | $31,871 | $48,749 | $37,843 |
| Total Assets | $294,963 | $341,192 | $180,294 | $180,385 | $215,443 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 985 | 4,332 | 5,665 | 4,751 | 3,808 |
| Accrued Expenses | 40,878 | 32,493 | 21,445 | 11,362 | 11,023 |
| Other current liabilities | 500 | 327 | 133 | 83 | 95 |
| TOTAL | $46,350 | $46,904 | $49,467 | $16,476 | $15,132 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,341 | 9,752 | 22,224 | 280 | 206 |
| Other Non-Current Liabilities | 196,647 | 102,664 | 0 | 0 | 0 |
| TOTAL | $198,839 | $111,118 | $1,363 | $1,666 | $1,946 |
| Total Liabilities | $245,189 | $158,022 | $50,830 | $18,142 | $17,078 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,372 | 4,059 | 3,312 | 2,795 | 2,393 |
| Common Shares | 7 | 6 | 5 | 4 | 4 |
| Retained earnings | -873,338 | -673,748 | -495,341 | -366,104 | -256,527 |
| Other shareholders' equity | -37 | -244 | -217 | -274 | -282 |
| TOTAL | $49,774 | $183,170 | $129,464 | $162,243 | $198,365 |
| Total Liabilities And Equity | $294,963 | $341,192 | $180,294 | $180,385 | $215,443 |